NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $38.97 +0.11 (+0.28 %) (As of 08/22/2018 01:23 AM ET)Previous Close$38.86Today's Range$38.50 - $39.0352-Week Range$37.70 - $68.98Volume2.10 million shsAverage Volume2.62 million shsMarket Capitalization$8.60 billionP/E Ratio14.47Dividend Yield0.91%Beta1.27 Company ProfileAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania. Receive XRAY News and Ratings via Email Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Dental equipment & supplies Sub-IndustryHealth Care Supplies SectorMedical SymbolNASDAQ:XRAY CUSIP24903010 Webwww.dentsplysirona.com Phone717-845-7511 Debt Debt-to-Equity Ratio0.31 Current Ratio1.69 Quick Ratio1.10 Price-To-Earnings Trailing P/E Ratio14.47 Forward P/E Ratio18.83 P/E Growth2.24 Sales & Book Value Annual Sales$3.99 billion Price / Sales2.17 Cash Flow$11.3285 per share Price / Cash3.44 Book Value$28.86 per share Price / Book1.35 Profitability EPS (Most Recent Fiscal Year)$2.66 Net Income$-1,550,000,000.00 Net Margins-39.62% Return on Equity9.12% Return on Assets5.81% Miscellaneous Employees16,100 Outstanding Shares222,350,000Market Cap$8.60 billion DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions What is DENTSPLY SIRONA's stock symbol? DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY." How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA? DENTSPLY SIRONA announced a quarterly dividend on Tuesday, June 26th. Stockholders of record on Friday, September 28th will be given a dividend of $0.0875 per share on Friday, October 12th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Thursday, September 27th. View DENTSPLY SIRONA's Dividend History. How were DENTSPLY SIRONA's earnings last quarter? DENTSPLY SIRONA Inc (NASDAQ:XRAY) issued its quarterly earnings data on Tuesday, August, 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.01. The medical instruments supplier earned $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same quarter in the previous year, the firm posted $0.65 earnings per share. View DENTSPLY SIRONA's Earnings History. When is DENTSPLY SIRONA's next earnings date? DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Friday, November, 2nd 2018. View Earnings Estimates for DENTSPLY SIRONA. What guidance has DENTSPLY SIRONA issued on next quarter's earnings? DENTSPLY SIRONA issued an update on its FY18 earnings guidance on Tuesday, August, 7th. The company provided earnings per share (EPS) guidance of $2.00-2.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.57. The company issued revenue guidance of $3.9 billion, compared to the consensus revenue estimate of $4.17 billion. What price target have analysts set for XRAY? 13 equities research analysts have issued 1 year price targets for DENTSPLY SIRONA's stock. Their predictions range from $38.00 to $75.00. On average, they expect DENTSPLY SIRONA's stock price to reach $52.1818 in the next year. This suggests a possible upside of 33.9% from the stock's current price. View Analyst Price Targets for DENTSPLY SIRONA. What is the consensus analysts' recommendation for DENTSPLY SIRONA? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for DENTSPLY SIRONA. What are Wall Street analysts saying about DENTSPLY SIRONA stock? Here are some recent quotes from research analysts about DENTSPLY SIRONA stock: 1. Barrington Research analysts commented, "We are cutting our investment rating to MARKET PERFORM in response to XRAY’s weak financial guidance for the remainder of FY/18 and the massive uncertainty we still see surrounding this business beyond this year. This update marks a new low in DENTSPLY SIRONA’s disappointing 2 ½ year history as a combined publicly-traded company." (8/9/2018) 2. HC Wainwright analysts commented, "Our price target is derived from a comparable universe-based approach, which utilizes a price-to-earnings (P/E) multiple calculated from a group of peer companies in the medical and dental equipment arenas." (8/8/2018) 3. According to Zacks Investment Research, "DENTSPLY underperformed the industry in a year’s time. A lowered guidance is discouraging. The company's higher capital expenditure on product development and tough competition are expected to exert pressure on margins. Unfavorable foreign exchange rate and integration risks are major headwinds for the near term. The stock is overvalued at the moment. On the brighter side, the company is likely to gain from robust performance in the flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwig Patterson Companies in Canada are likely to drive sales. DENTSPLY recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia." (8/6/2018) 4. Jefferies Financial Group Inc analysts commented, "Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR." (4/16/2018) Are investors shorting DENTSPLY SIRONA? DENTSPLY SIRONA saw a increase in short interest in July. As of July 31st, there was short interest totalling 9,481,193 shares, an increase of 29.0% from the July 13th total of 7,349,832 shares. Based on an average trading volume of 2,208,648 shares, the short-interest ratio is presently 4.3 days. Currently, 4.2% of the company's stock are short sold. View DENTSPLY SIRONA's Current Options Chain. Who are some of DENTSPLY SIRONA's key competitors? Some companies that are related to DENTSPLY SIRONA include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), BIOLASE (BIOL), Biomerica (BMRA) and Remedent (REMI). Who are DENTSPLY SIRONA's key executives? DENTSPLY SIRONA's management team includes the folowing people: Mr. Nicholas William Alexos, Exec. VP & CFO (Age 54)Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 49)Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 57)Mr. Robert J. Size, Interim Pres & COO (Age 59)Mr. Donald M. Casey Jr., CEO & Director (Age 58) Has DENTSPLY SIRONA been receiving favorable news coverage? Media stories about XRAY stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DENTSPLY SIRONA earned a media and rumor sentiment score of 0.12 on Accern's scale. They also assigned press coverage about the medical instruments supplier an impact score of 47.35 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for DENTSPLY SIRONA. Who are DENTSPLY SIRONA's major shareholders? DENTSPLY SIRONA's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.20%), Veritas Asset Management LLP (4.44%), Massachusetts Financial Services Co. MA (2.30%), Bank of America Corp DE (1.40%), Orbimed Advisors LLC (1.08%) and Macquarie Group Ltd. (1.06%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA. Which major investors are selling DENTSPLY SIRONA stock? XRAY stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Millennium Management LLC, Putnam Investments LLC, Victory Capital Management Inc., SG Americas Securities LLC, Select Equity Group L.P., FMR LLC and Nomura Holdings Inc.. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Francis J Lunger, Michael C Alfano and Michael J Coleman. View Insider Buying and Selling for DENTSPLY SIRONA. Which major investors are buying DENTSPLY SIRONA stock? XRAY stock was purchased by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Veritas Asset Management LLP, Nuance Investments LLC, Thompson Siegel & Walmsley LLC, Bank of America Corp DE, Mawer Investment Management Ltd., Douglas Lane & Associates LLC and Anchor Capital Advisors LLC. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA. How do I buy shares of DENTSPLY SIRONA? Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is DENTSPLY SIRONA's stock price today? One share of XRAY stock can currently be purchased for approximately $38.97. How big of a company is DENTSPLY SIRONA? DENTSPLY SIRONA has a market capitalization of $8.60 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. DENTSPLY SIRONA employs 16,100 workers across the globe. How can I contact DENTSPLY SIRONA? DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected] MarketBeat Community Rating for DENTSPLY SIRONA (NASDAQ XRAY)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 286 (Vote Outperform)Underperform Votes: 292 (Vote Underperform)Total Votes: 578MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/22/2018 by MarketBeat.com StaffFeatured Article: What do I need to know about analyst ratings?